Perfil epidemiológico y factores pronósticos del mieloma múltiple Hospital Luis Vernaza hospitalización 2013-2016
Fecha
2017
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Carrera de Medicina
Resumen
El Mieloma múltiple (MM) es un tipo de cáncer hematopoyético casi desconocido para la población general, cuya alteración se basa en la proliferación de células plasmáticas a nivel de médula ósea. Este estudio se basa en la recopilación, por un periodo de 4 años, de pacientes diagnosticados con mieloma múltiple en el hospital Luis Vernaza, donde se recolectó datos de laboratorio e imágenes con la finalidad de presentar un estadiaje general de los pacientes. Se obtuvieron 49 pacientes para el estudio 31 hombres y 18 mujeres, en edades comprendidas desde los 40 a 81 años de edad, con tales datos se pudo concluir que en cuanto al sexo y a la edad se encuentra en igual prevalencia que a nivel mundial. Se evidenció que muchos de los pacientes diagnosticados presentan un estadio avanzado de la enfermedad por lo que la mayoría tiene un mal pronóstico de vida.
Multiple myeloma (MM) is a type of hematopoietic cancer almost unknown for the general population whose alteration is based on the proliferation of plasma cells at bone marrow level. This study is based on the collection, for a period of 4 years, of patients diagnosed with multiple myeloma at the Luis Vernaza Hospital, where laboratory data and images were collected in order to present a general staging of the patients. We obtained 49 patients for the study 31 men and 18 women, aged between 40 and 81 years of age, with such data could be concluded that in terms of sex and age is in the same prevalence as in the world. It was evidenced that many of the patients diagnosed have an advanced stage of the disease so the majority have a poor prognosis of life.
Multiple myeloma (MM) is a type of hematopoietic cancer almost unknown for the general population whose alteration is based on the proliferation of plasma cells at bone marrow level. This study is based on the collection, for a period of 4 years, of patients diagnosed with multiple myeloma at the Luis Vernaza Hospital, where laboratory data and images were collected in order to present a general staging of the patients. We obtained 49 patients for the study 31 men and 18 women, aged between 40 and 81 years of age, with such data could be concluded that in terms of sex and age is in the same prevalence as in the world. It was evidenced that many of the patients diagnosed have an advanced stage of the disease so the majority have a poor prognosis of life.
Descripción
PDF
Palabras clave
Mieloma múltiple, Perfil de salud, Hospital Luis Vernaza, Cantón Guayaquil, Ecuador, Pronóstico